CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 138 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2016. The put-call ratio across all filers is 1.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $140,931,000 | +14.2% | 1,246,067 | +1.1% | 0.04% | +7.3% |
| Q1 2017 | $123,403,000 | +1.4% | 1,232,413 | +8.9% | 0.04% | 0.0% |
| Q4 2016 | $121,695,000 | -6.1% | 1,131,835 | +8.7% | 0.04% | -8.9% |
| Q3 2016 | $129,576,000 | +25.6% | 1,040,940 | +7.2% | 0.04% | +18.4% |
| Q2 2016 | $103,194,000 | +6.1% | 970,602 | +14.3% | 0.04% | -5.0% |
| Q1 2016 | $97,219,000 | +1162.6% | 849,216 | +1471.1% | 0.04% | +1233.3% |
| Q4 2015 | $7,700,000 | +84.2% | 54,054 | +16.1% | 0.00% | +50.0% |
| Q3 2015 | $4,181,000 | -21.9% | 46,543 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $5,353,000 | +2.1% | 46,475 | -15.4% | 0.00% | 0.0% |
| Q1 2015 | $5,244,000 | +16.1% | 54,910 | -18.3% | 0.00% | 0.0% |
| Q4 2014 | $4,518,000 | -1.7% | 67,198 | -21.1% | 0.00% | 0.0% |
| Q3 2014 | $4,594,000 | +51.3% | 85,122 | +24.6% | 0.00% | +100.0% |
| Q2 2014 | $3,037,000 | +0.3% | 68,306 | -21.6% | 0.00% | 0.0% |
| Q1 2014 | $3,027,000 | +4.6% | 87,096 | -13.2% | 0.00% | 0.0% |
| Q4 2013 | $2,895,000 | -5.6% | 100,337 | -4.5% | 0.00% | 0.0% |
| Q3 2013 | $3,068,000 | +44.7% | 105,073 | +14.9% | 0.00% | 0.0% |
| Q2 2013 | $2,120,000 | – | 91,413 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPQ Asia Capital Ltd | 287,277 | $35,760,000 | 28.32% |
| WARBURG PINCUS LLC | 6,674 | $830,780,000 | 13.45% |
| Ariose Capital Management Ltd | 238,841 | $27,689,000 | 7.56% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 12,600 | $1,568,000 | 4.48% |
| RUDMAN ERROL M | 37,001 | $4,606,000 | 3.72% |
| INDUS CAPITAL PARTNERS, LLC | 245,237 | $30,527,000 | 2.89% |
| Ativo Capital Management LLC | 93,784 | $11,674,000 | 2.70% |
| OBERWEIS ASSET MANAGEMENT INC/ | 63,305 | $7,880,000 | 2.27% |
| Point72 Hong Kong Ltd | 31,500 | $3,921,000 | 2.14% |
| Cormorant Asset Management, LP | 112,867 | $14,050,000 | 1.55% |